Comparison of Eye Movement Desensitization and Reprocessing (EMDR) and Duloxetine Treatment Outcomes in Women Patients with Somatic Symptom Disorder

Basit Öğe Kaydı
dc.authorscopusid57192554423
dc.authorscopusid56537032300
dc.authorscopusid56414216300
dc.authorscopusid24461033100
dc.contributor.authorDemirci, Onur Okan
dc.contributor.authorSa?altici, Eser
dc.contributor.authorYildirim, Abdullah
dc.contributor.authorBoysan, Murat
dc.date.accessioned2024-09-11T19:57:39Z
dc.date.available2024-09-11T19:57:39Z
dc.date.issued2017
dc.departmentİstanbul Gelişim Üniversitesien_US
dc.description.abstractSomatic symptom disorder (SSD) is a debilitating disorder that significantly diminishes quality of life and causes psychological distress such as anxiety and depression. The paper explored the efficiency of the eye movement desensitization and reprocessing (EMDR) therapy in SSD. The current investigation is a clinical trial investigating the effectiveness of eye movement desensitization (EMDR) therapy in the treatment of 31 first-diagnosed SSD patients in comparison to age, education and marital status matched 31-first-diagnosed SSD patients who received duloxetine over a 6-week course of treatment. Somatization subscale of the Symptom Checklist-Revised 90 (SCL-90), Beck Anxiety Inventory (BAI), Beck Depression Inventory (BDI), and Short Form Health Survey (SF-36) were administered to the participants. EMDR group showed enhanced improvement relative to baseline after 6 weeks of treatment compared to duloxetine group. We concluded that EMDR appears to be a highly promising therapy and should be considered among the first-line interventions in the treatment of SSD.en_US
dc.identifier.doi10.5350/Sleep.Hypn.2017.19.0146
dc.identifier.endpage77en_US
dc.identifier.issn1302-1192en_US
dc.identifier.issue3en_US
dc.identifier.scopus2-s2.0-85029947751en_US
dc.identifier.scopusqualityQ4en_US
dc.identifier.startpage70en_US
dc.identifier.urihttps://doi.org/10.5350/Sleep.Hypn.2017.19.0146
dc.identifier.urihttps://hdl.handle.net/11363/8327
dc.identifier.volume19en_US
dc.indekslendigikaynakScopusen_US
dc.language.isoenen_US
dc.publisherKure Iletisim Grubu A.S.en_US
dc.relation.ispartofSleep and Hypnosisen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.snmz20240903_Gen_US
dc.subjectClinical trial; Emotion dysregulation; Quality of life; Selective serotonin and norepinephrine reuptake inhibitor (SNRI); Somatoform disorders; Treatment efficacyen_US
dc.titleComparison of Eye Movement Desensitization and Reprocessing (EMDR) and Duloxetine Treatment Outcomes in Women Patients with Somatic Symptom Disorderen_US
dc.typeArticleen_US

Dosyalar

Koleksiyon

Scopus İndeksli Yayınlar Koleksiyonu